PreprintAll rights reservedbioRxiv3 Sep 2026

DLL3 expression predicts response and long-term outcome in small cell lung cancer patients treated with tarlatamab

B. Zhang
L. Hong
K. Wang
C. A. Stewart
K. Shah
W.-l. Wang
A. Serrano
L. M. Solis Soto
R. J. Cardnell
A. Halliday
M. Parma
E. R. Lopez

11 more authors

M. Bose
C. Ruoff
S. Ehsan
K. Ramkumar
T. Li
R. Zheng
L. G. Karacosta
J. Zhang
J. V. Heymach
C. M. Gay
L. A. Byers¹

¹The University of Texas MD Anderson Cancer Center

Read full text PDF DOI Cite

Clinicopathological Features of DLL3 Expression and T-Cell Infiltration in LCNEC: Insights From Pathology and Clinical Response to Tarlatamab.
Shotaro Kaneko, Naoki Furuya, Yoshihisa Sugiura +8
Thoracic cancer1 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Pan-Cancer Gene Expression Predicts Per-Cancer Radiation Therapy Response
Harry Glickman, Shirin A. Enger
Advances in radiation oncology27 Jul 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Predictive markers of response and toxicity to tarlatamab in patients with extensive stage small cell lung cancer: a multi-institutional real-world analysis
G. Fenton, W. Guo, D. L. Hess +11
medRxiv2 Oct 2026PreprintCC BY-NC-NDFull textOncologymedRxiv
Cell Viability of the Administered Product Predicts Response to Stromal Vascular Fraction in Patients with Erectile Dysfunction Unresponsive to Phosphodiesterase Type 5 Inhibitors
Ahmet Semih Güleser, Atakan Eren, Fatih Altunrende +2
Medicina (Kaunas, Lithuania)1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Tumor SETDB1 expression predicts worse overall survival for bladder cancer patients
Sarah Athans, Meegan Young, Han Yu +5
bioRxiv23 Oct 2026PreprintCC BY-NCFull textOncologybioRxivPMC

Cite

BibTeX RIS

BibTeX

@misc{zhang2026dll3,
  title = {{DLL3 expression predicts response and long-term outcome in small cell lung cancer patients treated with tarlatamab}},
  author = {B. Zhang and L. Hong and K. Wang and C. A. Stewart and K. Shah and W.-l. Wang and A. Serrano and L. M. Solis Soto and R. J. Cardnell and A. Halliday and M. Parma and E. R. Lopez and M. Bose and C. Ruoff and S. Ehsan and K. Ramkumar and T. Li and R. Zheng and L. G. Karacosta and J. Zhang and J. V. Heymach and C. M. Gay and L. A. Byers},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.03.749238},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.03.749238v1},
}

RIS

TY  - UNPB
TI  - DLL3 expression predicts response and long-term outcome in small cell lung cancer patients treated with tarlatamab
AU  - B. Zhang
AU  - L. Hong
AU  - K. Wang
AU  - C. A. Stewart
AU  - K. Shah
AU  - W.-l. Wang
AU  - A. Serrano
AU  - L. M. Solis Soto
AU  - R. J. Cardnell
AU  - A. Halliday
AU  - M. Parma
AU  - E. R. Lopez
AU  - M. Bose
AU  - C. Ruoff
AU  - S. Ehsan
AU  - K. Ramkumar
AU  - T. Li
AU  - R. Zheng
AU  - L. G. Karacosta
AU  - J. Zhang
AU  - J. V. Heymach
AU  - C. M. Gay
AU  - L. A. Byers
PY  - 2026
DA  - 2026/09/03
PB  - bioRxiv
DO  - 10.64898/2026.09.03.749238
UR  - https://www.biorxiv.org/content/10.64898/2026.09.03.749238v1
ER  -

Related

Cite